ZSX Medical, LLC
ZSX Medical makes the hardest part of surgery easy with a simple, cost-saving, and effective means to close internal surgical incisions in hysterectomy.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Philadelphia, PA, US
- Currency USD
- Founded June 2009
- Employees 4
- Incorporation Type LLC
- Website zipstitch.com
Company Summary
ZSX Medical is focused on developing products to help surgeons do their work more effectively and easily. We believe that making surgeons' work easier will help patients, save hospitals money, and reduce overall healthcare costs.
Our lead product, Zip-stitch, is currently being tested in real clinical use. Zip-stitch is the lead application in a platform of wound closure devices intended to address identified needs in surgical closure.
Team
-
President & CEODan Mazzucco, Ph.D., has been in the medical device industry for 20+ years. Prior to joining ZSX Medical, Dr. Mazzucco directed manufacturing, preclinical, clinical, and regulatory development at Aqumen Biopharmaceuticals, a Japanese ophthalmic biotechnology startup. Dr. Mazzucco earned a doctorate in medical and mechanical engineering from Harvard Medical School and MIT in the Division of Health Sciences and Technology.
-
Chief Technology OfficerAnthony Bellezza is a serial entrepreneur with experience in technology development and business management in early-stage medical device companies. He has 15+ years of experience in identifying, financing, and introducing early or seed-stage technologies to the marketplace. He is the Principal Investigator on seven state and federal grants, including multiple Phase I and Phase II SBIR grants from NSF.
-
John CrombieVP Product DevelopmentJohn Crombie leads engineering and product development. Mr. Crombie has 30 years of experience as a successful product & portfolio developer for diverse markets (surgical, diagnostic, therapeutic, and consumer) and diverse specialties, including with Pfizer, Ethicon, and J&J. Among 70 issued patents and across seven companies, Mr. Crombie has maintained a 70% commercialization rate of intellectual property.
Advisors
-
Saul Ewing, LLPLawyerUnconfirmed
Jennifer Anderson, LLCAccountantUnconfirmed
Broad Street AngelsUnconfirmed
Previous Investors
-
Feta Med/FoundersUnconfirmed
Kereitsu Forum Mid-atlanticUnconfirmed
Rowan Innovation Venture FundUnconfirmed -
Keiretsu Forum SoutheastUnconfirmed
Keiretsu Forum Pacific NorthwestUnconfirmed
Various other angel investorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.